Efficacy and safety of ainuovirine versus efavirenz combination therapies with lamivudine/tenofovir disoproxil fumarate for medication of treatment-naïve HIV-1-positive adults: week 48 results of a randomized controlled phase 3 clinical trial followed by an open-label setting until week 96.
第一作者:
Bin,Su
第一单位:
Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China.
作者:
DOI
10.1016/j.lanwpc.2023.100769
PMID
37547039
发布时间
2023-08-08
- 浏览0
The Lancet regional health. Western Pacific
2023年36卷
100769页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文